Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Amazoncom Inc AMZN Assessing AI Data Center Capacity Risks Amid IndustryWide Capex Expansion Lexaria Bioscience LEXX retreats 5 despite EPS beating estimates by 38 with 52 revenue growth Edison International EIX Q1 2026 Earnings Meet Consensus Analysts Hold Steady Outlooks Amid Sector Growth Disparities CODX CoDiag stock falls 613 despite Q4 2025 earnings landing slightly ahead of analyst expectations Georgia Governor Race TrumpEndorsed Burt Jones and Healthcare Mogul Rick Jackson Secure GOP Runoff Spots Gold and Silver Rates May Remain Volatile in 2026 as Crude Oil Dominates Indias External Balance TotalEnergies SE TTE Q1 2026 Earnings Surprise EPS 245 Up Significant Mobile Infrastructure BEEP Q1 2026 Earnings NarrowerThanExpected Loss and Surprise EPS Beat Quantum Computing Stocks Surge on 2 Billion US Government Funding Plan Social Security Claiming Dilemma Early Benefits at 62 vs Survivors Option at 67 for LowerIncome Retirees Saudi Arabias Vision 2030 Spending Spree Faces a Reality Check Jim Cramers Investing Club Highlights Diversification Beyond AI in Monthly Update Michael Saylor Tokenization Could Allow Investors to Shop for Yield Challenging Traditional Banking Ferrari Launches First AllElectric Model FourDoor Luce Priced at 640000 PGY Q1 2026 Earnings Massive EPS Beat Shocks Analysts Stock Surges SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher JJSF Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures SPRU Q1 2026 Earnings EPS Loss of 016 Per Share No Revenue Disclosed OFS Credit Company Inc Q1 2026 Earnings Significant EPS Miss Driven by Investment Losses Royal Bank of Canada Q1 2026 Earnings EPS Tops Estimates by 103 Stock Edges Lower Franklin Limited Duration Income Trust FTF Edges Higher as Yield Seekers Reassess Rate Outlook Aclaris Therapeutics Holds Steady Near MidRange as Traders Eye Key Support and Resistance TIC Solutions Inc TIC Holds Steady at 852 as Shares Consolidate Between Key Levels Nuveen Mortgage and Income Fund JLS Sees Minor Dip Amid Steady Trading OptimizeRx Holds Steady at 494 as Traders Await a Catalyst